Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
Clinical trial NCT05707819 · RECRUITING
Trial details
- NCT number
- NCT05707819
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-30
- Primary completion
- 2023-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.